+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adocia - logo

Adocia is a biotechnology company which focuses on producing treatments for diabetes. It was founded in 2005, and headquartered in Lyon, France. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas. There pipeline of products include: Biochaperone Lispro, Biochaperone Combo, Hinsbet, Biochaperone Human Glucagon, Biochaperone Glargine GLP-1, Biochaperone Prandial combinations for T1D.

From
From
From
Type 2 Diabetes Mellitus- Pipeline Insight, 2022 - Product Thumbnail Image

Type 2 Diabetes Mellitus- Pipeline Insight, 2022

  • Drug Pipelines
  • March 2022
  • 100 Pages
From
From
From
From
Type 2 Diabetes - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1251 Pages
From
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 733 Pages
From
From
Hypoglycemia R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Hypoglycemia R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 81 Pages
From
Hypoglycemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Hypoglycemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 87 Pages
From
From
From
Loading Indicator